Enzo Biochem (ENZB) EPS by Year
Enzo Biochem Inc lost $0.51 per diluted share in fiscal year 2024. This represents a decrease of 224.4% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to a loss of $0.41 per diluted share. The table below carries 15 fiscal years, from 2010 to 2024, and the quarters Enzo Biochem Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ENZB EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing | FY19Filing | FY18Filing | FY17Filing | FY16Filing | FY15Filing | FY14Filing | FY13Filing | FY12Filing | FY11Filing | FY10Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (Diluted) | -$0.41 | -$0.51-224.4% | $0.41n/m | -$0.38-337.5% | $0.16n/m | -$0.60 | $0.05 | -$0.22 | -$0.05-105.2% | $0.97n/m | -$0.05n/m | -$0.23n/m | -$0.46 | -$1.01n/m | -$0.34n/m | -$0.59 |
TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
ENZB EPS (Diluted) by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What diluted earnings per share means
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.